The effect of formoterol inhalation on endurance performance in hypobaric conditions

Medicine and Science in Sports and Exercise

Volumn 38, Issue 12, 2006, Pages 2132-2137

  Riiser, Amund ^a,c   Tjørhom, Anette ^a,c   Carlsen, Kai Håkon ^a,b,c  

^a NORWEGIAN SCHOOL OF SPORT SCIENCES   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c Oslo Research Group of Asthma Allergy in Children Lung and the Environment   (Norway)

Author keywords

Endurance; Healthy subjects; High altitude; Long acting 2 agonists

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; FORMOTEROL; LACTIC ACID; OXYHEMOGLOBIN; PLACEBO;

ADULT; ALTITUDE; ARTERIAL OXYGEN SATURATION; ARTICLE; ATHLETE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOPING; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENDURANCE; EXERCISE INDUCED ASTHMA; EXHAUSTION; FORCED EXPIRATORY VOLUME; HEART RATE; HUMAN; HUMAN EXPERIMENT; HYPOBARISM; LACTATE BLOOD LEVEL; LUNG FUNCTION; LUNG VENTILATION; MALE; NORMAL HUMAN; OXYGEN CONSUMPTION; PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; RUNNING; SCREENING TEST; SINGLE DRUG DOSE; SPORT; WARMING;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; ADULT; ALTITUDE; DOUBLE-BLIND METHOD; ETHANOLAMINES; EXERCISE TEST; FORCED EXPIRATORY FLOW RATES; FORCED EXPIRATORY VOLUME; HEART RATE; HUMANS; LACTIC ACID; MALE; NEBULIZERS AND VAPORIZERS; OXYGEN; PHYSICAL ENDURANCE; RUNNING;

EID: 33845371123     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/01.mss.0000233801.46906.9b     Document Type: Article

References (27)

1. BEDI, J. F., H. GONG, JR., and S. M. HORVATH. Enhancement of exercise performance with inhaled albuterol. Can. J. Sport Sci. 13:144-148, 1988.
2. BORCH, K. W., F. INGJER, S. LARSEN, and S. E. TOMTEN. Rate of accumulation of blood lactate during graded exercise as a predictor of 'anaerobic threshold'. J. Sports Sci. 11:49-55, 1993.
3. CAMPBELL, L. M. From adrenaline to formoterol: advances in beta-agonist therapy in the treatment of asthma. Int. J. Clin. Pract. 56:783-790, 2002.
4. CARLSEN, K. H. Exercise induced asthma in children and adolescents and the relationship to sports. Pediatr. Allergy Immunol. 9:173-180, 1998.
5. CARLSEN, K. H., and J. BOE. Exercise-induced asthma in children. Eur. Respir. J. 6:614-616, 1993.
6. CARLSEN, K. H., E. HEM, T. STENSRUD, T. HELD, K. HERLAND, and P. MOWINCKEL. Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta2-agonist formoterol upon endurance performance in healthy well-trained athletes. Respir. Med. 95:571-576, 2001.
7. CARLSEN, K. H., F. INGJER, H. KIRKEGAARD, and B. THYNESS. The effect of inhaled salbutamol and salmeterol on lung function and endurance performance in healthy well-trained athletes. Scand. J. Med. Sci. Sports 7:160-165, 1997.
8. DEMPSEY, J. A., and H. V. FORSTER. Mediation of ventilatory adaptations. Physiol. Rev. 62:262-346, 1982.
9. DI PRAMPERO, P. E., G. ATCHOU, J. C. BRUCKNER, and C. MOIA. The energetics of endurance running 2. Eur. J. Appl. Physiol. Occup. Physiol. 55:259-266, 1986.
10. GOUBAULT, C., M. C. PERAULT, E. LELEU, et al. Enhancement of exercise performance with inhaled albuterol. Thorax 56:675-679, 2001.
11. HEIR, T., and S. OSEID. Self-reported asthma and exercise-induced asthma symptoms in high-level competitive cross-country skiers. Scand. J. Med. Sci. Sports 4:128-133, 1994.
12. HEIR, T., and H. STEMSHAUG. Salbutamol and high-intensity treadmill running in nonasthmatic highly conditioned athletes. Scand. J. Med. Sci. Sports 5:231-236, 1995.
13. JEUKENDRUP, A., W. H. SARIS, F. BROUNS, and A. D. KESTER. A new validated endurance performance test. Med. Sci. Sports Exerc. 28:266-270, 1996.
14. LARSSON, K., D. GAVHED, L. LARSSON, I. HOLMER, L. JORFELT, and P. OHLSEN. Influence of a beta2-agonist on physical performance at low temperature in elite athletes. Med. Sci. Sports Exerc. 29:1631-1636, 1997.
15. MEEUWISSE, W. H., D. C. MCKENZIE, S. R. HOPKINS, and J. D. ROAD. The effect of salbutamol on performance in elite nonasthmatic athletes. Med. Sci. Sports Exerc. 24:1161-1166, 1992.
16. MENIER, D. R., and L. G. PUGH. The relation of oxygen intake and velocity of walking and running, in competition walkers. J. Physiol. 197:717-721, 1968.
17. MORTON, A. R., K. JOYCE, S. M. PAPALIA, N. G. CARROLL, and K. D. FITCH. Is salmeterol ergogenic? Clin. J. Sport Med. 6:220-225, 1996.
18. NORRIS, S. R., S. R. PETERSEN, and R. L. JONES. The effect of salbutamol on performance in endurance cyclists. Eur. J. Appl. Physiol. Occup. Physiol. 73:364-368, 1996.
19. PREFAUT, C., F. DURAND, P. MUCCI, and C. CAILLAUD. Exercise-induced arterial hypoxaemia in athletes: a review. Sports Med. 30:47-61, 2000.
20. RUNDELL, K. W., J. IM, L. B. MAYERS, R. L. WILBER, L. SZMEDRA, and H. R. SCHMITZ. Self-reported symptoms and exercise-induced asthma in the elite athlete 50. Med. Sci. Sports Exerc. 33:208-213, 2001.
21. SQUIRES, R. W., and E. R. BUSKIRK. Aerobic capacity during acute exposure to simulated altitude, 914 to 2286 meters. Med. Sci. Sports Exerc. 14:36-40, 1982.
22. STEWART, I. B., J. M. LABRECHE, and D. C. MCKENZIE. Acute formoterol administration has no ergogenic effect in nonasthmatic athletes. Med. Sci. Sports Exerc. 34:213-217, 2002.
23. STEWART, I. B., J. M. LABRECHE, and D. C. MCKENZIE. Effect of a long- and short-acting beta2-agonist on exercise-induced arterial hypoxemia. Med. Sci. Sports Exerc. 35:603-607, 2003.
24. STROMME, S. B., and F. INGJER. High altitude training. Nord. Med. 109:19-22, 1994.
25. VAN BAAK, M. A., O. M. DE HON, F. HARTGENS, and H. KUIPERS. Inhaled salbutamol and endurance cycling performance in non-asthmatic athletes. Int. J. Sports Med. 25:533-538, 2004.
26. VOY, R. O. The U.S. Olympic committee experience with exercise-induced bronchospasm, 1984. Med. Sci. Sports Exerc. 18:328-330, 1986.
27. WEILER, J. M., and E. J. RYAN III. Asthma in United States Olympic athletes who participated in the 1998 Olympic winter games 1. J. Allergy Clin. Immunol. 106:267-271, 2000.